Section I. General Introduction • •
Section II. Method for the Quantitative Determination of small amounts of
Pregnanediol in Human Urine • •
Section III. Rapid Method for the Determination of Urinary Pregnanediol suitable
for routine clinical use • •
Section IV. The Conversion of Progesterone to Urinary Pregnanediol by Human
Subjects:
Introduction •
(1) Healthy Post -Menopausal Women •
(2) Healthy Young Men •
(3) Oestrogen pretreated Post-Menopausal Women •
(4) Hysterectomised Post-Menopausal Women •
(5) Hypertensive Cases •
(6) Administration of Pregnanediol or Sodium pregnanediol glucuronidate •
(7) Continued Daily Administration of Progesterone to Post-Menopausal Women and Young Men • •
Section V. Effect of Administration of Progesterone on Excretion of Pregnanediol during Normal Pregnancy • •
Section VI. Excretion of Urinary Pregnanediol after Excision of the Corpus Luteum of Pregnancy • •
Section VII. Effect of Diethylstilboestrol Administration on Excretion of Pregnanediol in Normal and Diabetic Pregnancy • •
Section VIII. Interpretation • •
References • •
Publication
